IPCA Laboratories Ltd
NSE:IPCALAB

Watchlist Manager
IPCA Laboratories Ltd Logo
IPCA Laboratories Ltd
NSE:IPCALAB
Watchlist
Price: 1 438.55 INR -0.57%
Market Cap: 365B INR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+48%
Revenue
Forecast
+7%
Operating Income
Forecast
+4%
Net Income
Forecast
+5%

Wall Street
Price Targets

IPCALAB Price Targets Summary
IPCA Laboratories Ltd

Wall Street analysts forecast IPCALAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IPCALAB is 1 727.25 INR with a low forecast of 1 313 INR and a high forecast of 2 037 INR.

IPCALAB Lowest Forecast
Wall Street Target
1 313 INR
9% Downside
IPCALAB Average Forecast
Wall Street Target
1 727.25 INR
20% Upside
IPCALAB Highest Forecast
Wall Street Target
2 037 INR
42% Upside
Lowest
Price Target
1 313 INR
9% Downside
Average
Price Target
1 727.25 INR
20% Upside
Highest
Price Target
2 037 INR
42% Upside
IPCA Laboratories Ltd Competitors:
Price Targets
ROG
Roche Holding AG
5% Upside
C
214370
Caregen Co Ltd
57% Upside
1177
Sino Biopharmaceutical Ltd
28% Upside
300705
Hunan Jiudian Pharmaceutical Co Ltd
86% Upside
ROG
Roche Holding AG
5% Upside
C
214370
Caregen Co Ltd
57% Upside
1177
Sino Biopharmaceutical Ltd
28% Upside
300705
Hunan Jiudian Pharmaceutical Co Ltd
86% Upside
AGY
Allergy Therapeutics PLC
104% Upside
600196
Shanghai Fosun Pharmaceutical Group Co Ltd
12% Upside
UCB
Ucb SA
22% Upside
K
4521
Kaken Pharmaceutical Co Ltd
8% Upside

Revenue
Forecast

Revenue Estimate
IPCA Laboratories Ltd

For the last 8 years the compound annual growth rate for IPCA Laboratories Ltd's revenue is 13%. The projected CAGR for the next 3 years is 15%.

13%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
IPCA Laboratories Ltd

For the last 8 years the compound annual growth rate for IPCA Laboratories Ltd's operating income is 24%. The projected CAGR for the next 3 years is 31%.

24%
Past Growth
31%
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
IPCA Laboratories Ltd

For the last 8 years the compound annual growth rate for IPCA Laboratories Ltd's net income is 25%. The projected CAGR for the next 3 years is 40%.

25%
Past Growth
40%
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

See Also

Summary
IPCALAB intrinsic value, competitors valuation, and company profile.
DCF Valuation
IPCALAB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IPCALAB stock valuation using valuation multiples.
Wall Street Estimates
IPCALAB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IPCALAB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IPCALAB's stock price target?
Price Target
1 727.25 INR

According to Wall Street analysts, the average 1-year price target for IPCALAB is 1 727.25 INR with a low forecast of 1 313 INR and a high forecast of 2 037 INR.

What is IPCA Laboratories Ltd's Revenue forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for IPCA Laboratories Ltd's revenue is 13%. The projected CAGR for the next 3 years is 15%.

What is IPCA Laboratories Ltd's Operating Income forecast?
Projected CAGR
31%

For the last 8 years the compound annual growth rate for IPCA Laboratories Ltd's operating income is 24%. The projected CAGR for the next 3 years is 31%.

What is IPCA Laboratories Ltd's Net Income forecast?
Projected CAGR
40%

For the last 8 years the compound annual growth rate for IPCA Laboratories Ltd's net income is 25%. The projected CAGR for the next 3 years is 40%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 241,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.